Considering tau vulnerability in the midbrain tegmentum in PSP34 and a preserved brainstem structure in mid- to late-stage CBS phenotypes10, the fixel-wise metrics along brainstem and SCP might provide a potential target for understanding the disease mechanisms in the context of differentiating PSP and CBS. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.